Germany-Wilhelmshaven: Social work and related services

Stadt Wilhelmshaven, FB 30 Rechtsamt, Zentrale Vergabestelle · Germany government procurement

This opportunity is now closed. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$0

Est. Value

Closed

Status

About this record

The issuing agency did not publish a description for this notice. The full record as GlobalGov received it is below.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Solicitation Details

Issuing agency	Stadt Wilhelmshaven, FB 30 Rechtsamt, Zentrale Vergabestelle
Country	Germany
Category	Pharmaceuticals
Estimated value	$0
CPV	85300000
Published	October 04, 2023
Procurement stage	Active solicitation
Closed	Closing date not published
Status	Closed — no longer accepting responses
Last verified	October 10, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Pharmaceuticals tenders in Germany →Browse all categories →

Browse Similar Open Opportunities in Germany

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Vareniclin (ATC: N07BA03)

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen im Rahmen eines sog. Open-House-Modells zu diversen Röntgenkontrastmitteln (ATC-Code nach WHO: V08)

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Octreotid, ATC H01CB02

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Peginterferon beta-1a, ATC L03AB13

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Certolizumab pegol (ATC-Code nach WHO: L04AB05)

Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient ciclosporin (ATC code: S01XA18).

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Sultamicillin (ATC-Code nach WHO: J01CR04)

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.11.2025 / 01.01.2026

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.